Evidence map›Paper›PMID 30607193›Full record

ArticleOpen access Macedonian journal of medical sciences2018

Comparative Analysis of the "Scholastic" Recommendations of the AJCC From 2011 for the Surgical Treatment of Cutaneous Melanoma with the Newly Suggested Guidelines for OSMS From the Bulgarian Society For Dermatologic Surgery!

Georgi Tchernev, Ivanka Temelkova

Abstract readCase Reports
In one paragraph

Article in Open access Macedonian journal of medical sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Georgi TchernevMedical Institute of Ministry of Interior (MVR), Department of Dermatology, Venereology and Dermatologic Surgery, General Skobelev Nr 79, Sofia, Bulgaria.
Ivanka TemelkovaMedical Institute of Ministry of Interior (MVR), Department of Dermatology, Venereology and Dermatologic Surgery, General Skobelev Nr 79, Sofia, Bulgaria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe American Joint Committee on Cancer (AJCC) offers a two-stage, often insufficient or so-called variable model of cutaneous melanoma treatment. This model starts with primary excision and an initial operational safety margin of 0.5 cm in all directions, followed by a re-excision with an additional field of operational security, determined by histologically established tumor thickness (with or without removal of SLN). We present a brand new method of melanoma surgery, the so-called One Step melanoma surgery (OSMS), in which cutaneous melanomas (regardless of their thickness) could be removed by single surgical intervention. CASE REPORT: We describe a case of a patient with cutaneous melanoma, with postoperatively established Breslow's tumor thickness of 6 mm, operated on the AJCC model within two surgical sessions. The usual primary excision was performed with a surgical safety margin of 0.5 cm in all directions, followed by a secondary excision with an additional surgical security field of 1.2 cm in all directions (due to the patient's wish for the optimal cosmetic result, agreed and approved by the dermatosurgeon performing the manipulation).

conclusionThe two-stage method for the treatment of melanomas is often insufficient due to: 1) the inability (in this case) secondary excision in the face area to be conducted with an additional recommended operational security field of 1.5 cm in all directions; and 2) the patient's wish for a better cosmetic result, which should be achieved with less surgical security field, resulting in a compromise solution for re-excision with an additional surgical field of 1.2 cm in all directions.

Indexed as

AJCC recommendationsOld schoolOne step melanoma surgerySurgical innovationSurvival benefitsTwo-step melanoma surgery model

Identifiers

PMID30607193
PMCPMC6311480

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.